Efficacy And Safety Of Abrocitinib In Patients With Moderate-To-Severe Atopic Dermatitis: Results From The Open-Label Run-In Period Of Jade Regimen

BRITISH JOURNAL OF DERMATOLOGY(2021)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要